Jashvik Capital yesterday appointed Anil Matai and Vijender Singh as Operating Partners, a statement from Jashvik Capital said.
According to the statement, Singh was most recently CEO of Metropolis Healthcare and COO of Dr Lal Pathlabs. He helped scale both these companies under private equity ownership. Previously, he held leadership roles at Ranbaxy Labs, in their OTC/Wellness business, and at Bausch and Lomb. Matai was most recently Managing Director of Zydus Healthcare and CEO of Novartis Pharma India. Previously, he also held leadership positions at GlaxoSmithKline India.
Naresh Patwari, Founder, Jashvik Capital, said in the statement, “We are excited to announce that Anil and Vijender are joining Jashvik Capital to help drive our mission. They have deep networks in healthcare/pharma and various consumption-linked sectors. Anil and Vijender have decades-long experience in building the best-in-class organisations, scaling them and establishing commanding market leadership positions.
In the statement, Singh said, “I am excited about the opportunity to be part of this mission. As India aims to grow from a $3 trillion to a $30 trillion economy, healthcare and consumer sectors will account for a disproportionate share of that growth and high-quality, profitable growth businesses in the mid-market will be fundamental to delivering on this opportunity. We want to partner with the founders of these businesses and help them realise their vision and strategies.”
Matai also said in the statement, “At Jashvik Capital, we aspire to build an outstanding firm that is anchored in our core values. We intend to be aligned and trusted partners of all our stakeholders. I am excited about being part of this journey. We want to partner with exceptional founders and management teams and support them as they scale their businesses in an accelerated, profitable and sustainable manner.”